ITGR (Integer Holdings) ROCE %: 3.57% (As of Mar. 2026)


ITGR Integer Holdings Corp ITGR
85 GF Score
Price $91.38
GF Value $117.19
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Integer Holdings ROCE %?

Integer Holdings ITGR +2.05% 85 ROCE % is 3.57% as of Mar. 2026. GuruFocus rates ITGR with a GF Score™ of 85/100 and a GF Value™ of $117.19 (Modestly Undervalued). The stock has 1 warning sign investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Integer Holdings's annualized ROCE % for the quarter that ended in Mar. 2026 was 3.57%.


Integer Holdings  (NYSE:ITGR) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Integer Holdings ROCE % Related Terms


Integer Holdings ROCE % Historical Data

* Premium members only.

The historical data trend for Integer Holdings's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Integer Holdings ROCE % Chart

Integer Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.72 4.24 5.92 7.17 5.59

Integer Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.24 7.09 6.98 7.05 3.57
ITGR
85GF Score
Integer Holdings Corp ITGR
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Integer Holdings ROCE % Calculation

Integer Holdings's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=168.602/( ( (3077.971 - 227.173) + (3410.577 - 232.041) )/ 2 )
=168.602/( (2850.798+3178.536)/ 2 )
=168.602/3014.667
=5.59 %

Integer Holdings's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=113.84/( ( (3410.577 - 232.041) + (3411.719 - 206.344) )/ 2 )
=113.84/( ( 3178.536 + 3205.375 )/ 2 )
=113.84/3191.9555
=3.57 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 3.57% mean?
Integer Holdings (ITGR) has a ROCE % of 3.57% as of Mar. 2026.
Is Integer Holdings' ROCE % too high?
Integer Holdings' current ROCE % is 3.57%. The Medical Devices & Instruments industry median ROCE % is 2.23. Integer Holdings' value of 3.57% is 60.1% above this industry median. Overall, Integer Holdings has a GF Score™ of 85/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Integer Holdings' ROCE % compare to HAE and IRTC?
Integer Holdings' ROCE % of 3.57% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.23. Integer Holdings' value of 3.57% is 60.1% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 2.23, based on 814 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Integer Holdings's current ROCE % of 3.57% is 60.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Integer Holdings's current ROCE % is 3.57%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Integer Holdings stock overvalued right now?
Based on GuruFocus' analysis, Integer Holdings (ITGR) is currently considered Modestly Undervalued. The stock's GF Value™ is $117.19, compared to a current price of $91.38 — trading 22% below its estimated fair value. The current ROCE % is 3.57% and 60.1% above the Medical Devices & Instruments industry median of 2.23. Integer Holdings' overall GF Score™ is 85/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Integer Holdings (ITGR), the current ROCE % is 3.57% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Integer Holdings (ITGR) Overvalued in 2026?

Based on GuruFocus' analysis, Integer Holdings stock appears to be undervalued. The current stock price of $91.38 is trading 22% below its estimated GF Value™ of $117.19. GuruFocus considers Integer Holdings to be Modestly Undervalued.

Key valuation signals for ITGR:

  • ROCE %: 3.57%
  • GF Value™: $117.19 vs. price of $91.38 (22% below fair value)
  • GF Score™: 85/100 with 1 warning sign
  • Industry Position: 60.1% above the Medical Devices & Instruments median

No single metric tells the full story. See the ITGR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Integer Holdings Business Description

Other Exchanges WGB:Germany
Address 5830 Granite Parkway, Suite 1150, Plano, TX, USA, 75024
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns maximum of its revenue in the United States, and also has its presence in Ireland, Puerto Rico, Costa Rica, and Rest of the World.
85GF Score

Get the complete analysis for ITGR

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$91.38
Price
$117.19
GF Value